In Vivo Activation of T-Cell Proliferation by Regulating Cell Surface Receptor Clustering Using a pH-Driven Interlocked DNA Nano-Spring
Source abstract
Abstract
Activation of T-cell proliferation specifically in a tumor is crucial for reducing the autoimmune side effects of antitumor immunotherapy. Herein, we developed a pH-driven interlocked DNA nano-spring (iDNS) to stimulate T-cell activation in vivo in response to the low pH value in a tumor microenvironment. The interlocked structure of iDNS provide a more rigid scaffold in comparison to double-stranded DNA for ligand assembly, which can help to control the spatial distribution of ligands with more accuracy. We have demonstrated that the pH-driven reversible reconfiguration of iDNS provides a powerful way to regulate the nanoscale distribution of T-cell receptors (CD3) on the cell surface. The relatively low pH value (pH 6.5) in a solid tumor was able to drive the springlike shrinking of iDNS and induce significant T-cell proliferation, leading to an enhanced antitumor effect, thus providing a tool for specifically inducing an immune response in a tumor for immunotherapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Immunotherapy and Immune Responses · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, State Key Laboratory of Esophageal Cancer Prevention & Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Zhengzhou University, Zhengzhou 450001, People’s Republic of China
Funding
China Postdoctoral Science Foundation · National Natural Science Foundation of China
References (32)
Show source-provided references
1. 10.1038/s41571-018-0142-810.1038/s41571-018-0142-8 ↗
2. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
3. 10.1038/nbt.404710.1038/nbt.4047 ↗
4. 10.1002/anie.20180900610.1002/anie.201809006 ↗
5. 10.1021/acsami.0c1995510.1021/acsami.0c19955 ↗
6. 10.1038/nri288710.1038/nri2887 ↗
7. 10.3389/fimmu.2016.0025510.3389/fimmu.2016.00255 ↗
8. 10.1038/nri114810.1038/nri1148 ↗
9. 10.1073/pnas.071029510510.1073/pnas.0710295105 ↗
10. 10.1021/acs.nanolett.1c0107310.1021/acs.nanolett.1c01073 ↗
11. 10.1002/anie.20200336710.1002/anie.202003367 ↗
12. 10.1002/adma.20180735910.1002/adma.201807359 ↗
13. 10.1021/nl402262310.1021/nl4022623 ↗
14. 10.1021/acs.nanolett.7b0373410.1021/acs.nanolett.7b03734 ↗
15. 10.1021/nl403252x10.1021/nl403252x ↗
16. 10.1021/nl403266t10.1021/nl403266t ↗
17. 10.1002/adma.20100044510.1002/adma.201000445 ↗
18. 10.1039/C9CS00473D10.1039/C9CS00473D ↗
19. 10.1039/C7SC02489D10.1039/C7SC02489D ↗
20. 10.1002/anie.20210542510.1002/anie.202105425 ↗
21. 10.1038/nmeth.302510.1038/nmeth.3025 ↗
22. 10.1021/jacs.6b0069410.1021/jacs.6b00694 ↗
23. 10.1021/ja311822410.1021/ja3118224 ↗
24. 10.1002/adfm.20190565910.1002/adfm.201905659 ↗
25. 10.1002/anie.20035240210.1002/anie.200352402 ↗
26. 10.1002/adfm.20190625310.1002/adfm.201906253 ↗
27. 10.1073/pnas.90.11.530710.1073/pnas.90.11.5307 ↗
28. 10.1021/nn405520d10.1021/nn405520d ↗
29. 10.1146/annurev-physiol-021119-03462710.1146/annurev-physiol-021119-034627 ↗
30. 10.1016/j.biomaterials.2016.01.00810.1016/j.biomaterials.2016.01.008 ↗
31. 10.1002/adhm.20180039110.1002/adhm.201800391 ↗
32. 10.1038/s41565-020-00782-310.1038/s41565-020-00782-3 ↗